DOW LOHNES GOVERNMENT STRATEGIES LLC for APOTEX CORP
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.R. 3700 Fair Medicaid Drug Payment Act of 2007, provisions related to regulation of generic drugs and consumer access; H.R. 1902 Protecting Consumer Access to Generic Drugs Act of 2007, all provisions related to generic drug consumer access; H.R. 3610 Food and Drug Import Safety Act of 2007, provisions related to drug safety; H.R. 5629 Pathway for Biosimilars Act, all provisions related to FDA licensure of biogeneric drugs
Foreign entity interest: Apotex Holdings, Inc., the parent company of Apotex Corp., has direct and/or indirect ownership interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC S KESSLER | Chief of Staff, Hon. John D. Dingell |
| KENNETH D SALOMON New | — |
| STEPHEN C SAYLE New | Majority Counsel, House Energy and Commerce C |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.